Stay updated on Benralizumab in Chronic Urticaria Clinical Trial

Sign up to get notified when there's something new on the Benralizumab in Chronic Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Benralizumab in Chronic Urticaria Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T17:02:44.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the page. The government funding status notice and the prior revision notice for v3.4.1 were removed.
    Difference
    0.3%
    Check dated 2026-02-11T09:27:40.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide government funding status notice was added, stating that information may not be up to date and where to check for updates. The page revision tag was updated from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T06:22:33.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated metadata labels, including 'Last Update Submitted that Met QC Criteria' and the site revision tag 'Revision: v3.4.0'. The wording for FEAR Act data changed to 'No FEAR Act Data' and the corresponding label from the previous version ('No FEAR Act data' and 'Revision: v3.3.4').
    Difference
    0.1%
    Check dated 2026-01-28T04:30:14.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Minor UI/metadata update: Revision label updated from v3.3.3 to v3.3.4 on the page. This change does not affect study data, eligibility criteria, or how users interact with the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:44:44.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The page now includes a Locations section with state-level entries (Arizona, California, Florida, Georgia, Michigan, Ohio, Oklahoma, Texas) and the revision tag updated to v3.3.3, while the HHS Vulnerability Disclosure link is removed.
    Difference
    0.7%
    Check dated 2025-12-23T09:18:43.000Z thumbnail image

Stay in the know with updates to Benralizumab in Chronic Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Benralizumab in Chronic Urticaria Clinical Trial page.